C. Barry

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Clifton E. 3rd Barry, Clifton E. Barry, Clifton E Barry, C. Barry, Clifton Barry, C E Barry, C. E. Barry
Publication record
95 papers · 8,607 citations · H-index 38

PAPERS

Optimization and Application of a T cell Antigen-Specific Activation Assay as Diagnostic and Treatment Monitoring Tool for Tuberculosis
20250 citationsauthor #18
Mathematical model of oxygen, nutrient, and drug transport in tuberculosis granulomas
20246 citationsauthor #8
Distributable, metabolic PET reporting of tuberculosis
20249 citationsauthor #29
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial
202429 citationsauthor #2
Leveraging insights from cancer to improve tuberculosis therapy.
20244 citationsauthor #5
Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbits
202415 citationsauthor #17
Distributable, Metabolic PET Reporting of Tuberculosis
202313 citationsauthor #29
A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum
202332 citationsauthor #12
Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel
20229 citationsauthor #2
A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case Study
202219 citationsauthor #15
Eosinophils are part of the granulocyte response in tuberculosis and promote host resistance in mice
202170 citationsauthor #24
Eosinophils are an integral component of the pulmonary granulocyte response in Tuberculosis and promote host resistance in mice
20211 citationsauthor #24
Signature required: The transcriptional response to tuberculosis
20212 citationsauthor #1
Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response
202037 citationsauthor #15
Linezolid resistance in patients with drug-resistant TB and treatment failure in South Africa
201942 citationsauthor #8
A semi-automatic technique to quantify complex tuberculous lung lesions on 18F-fluorodeoxyglucose positron emission tomography/computerised tomography images
201820 citationsauthor #11
Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis
201895 citationsauthor #8
Oxazolidinones are essential in resistance-proof drug combinations in M. tuberculosis selected under in vitro conditions
20180 citationsauthor #4
Corrigendum: Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
201787 citationsauthor #16
POLICY-DRIVEN INTERVENTIONS: TUBERCULOSIS
20170 citationsauthor #7
Correction: Corrigendum: Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
20170 citationsauthor #16
Interferon-gamma response to the treatment of active pulmonary and extra-pulmonary tuberculosis.
201717 citationsauthor #14
Evaluation of a Rapid Molecular Drug‐Susceptibility Test for Tuberculosis
2017134 citationsauthor #23
Corrigendum: Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
2017193 citationsauthor #16
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into emergence and spread of multidrug resistance
2017262 citationsauthor #8
Abstracts of the Eighth EDCTP Forum, 6–9 November 2016
20170 citationsauthor #12
The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy
20172 citationsauthor #19
Correction to Absolute Quantitative MALDI Imaging Mass Spectrometry: A Case of Rifampicin in Liver Tissues.
20163 citationsauthor #6
Persisting PET-CT lesion activity and M. tuberculosis mRNA after pulmonary tuberculosis cure
201678 citationsauthor #16
[18F]-FDG PET/CT characterisation of progressive HIV-associated tuberculosis
20160 citationsauthor #15
Inflammatory signaling in human Tuberculosis granulomas is spatially organized
2016265 citationsauthor #14
Accuracy of a Highly Multiplexed, Ten-Color, Point-of-Care Assay for Rapid Mycobacterium tuberculosis Drug Susceptibility Testing: A Prospective, Multicenter Study
20160 citationsauthor #13
Absolute Quantitative MALDI Imaging Mass Spectrometry: A Case of Rifampicin in Liver Tissues.
2016163 citationsauthor #6
Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB
201645 citationsauthor #12
More than just bugs in spit
20154 citationsauthor #1
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
2015333 citationsauthor #2
Erratum: Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage (Nat. Genet. (2015) DOI: 10.1038/ng.3195)
20157 citationsauthor #17
Timing is everything for compassionate use of delamanid
201513 citationsauthor #1
Abstract B19: Anti-VEGF treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery
20151 citationsauthor #13
Treatment of Tuberculosis.
2015132 citationsauthor #3
Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery
2015189 citationsauthor #13
Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage
2015513 citationsauthor #17
The Death of the "Three Ms".
20151 citationsauthor #1
Mathematical Model of Oxygen Transport in Tuberculosis Granulomas
201538 citationsauthor #6
reportMetaplastic ossification in the cartilage of the bronchus of a patient with chronic multi-drug resistant tuberculosis : a case report
20150 citationsauthor #7
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
2014725 citationsauthor #18
Running title: Aminoglycoside resistance detection in M. tuberculosis. 5
20140 citationsauthor #9
PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis
2014129 citationsauthor #25
Characterisation Of A Whole Blood Transcriptional Signature Of Subclinical Tuberculosis Identified By Fdg-Pet/ct In Asymptomatic Hiv-1 Infected Adults
20140 citationsauthor #9
The ongoing challenge of latent tuberculosis
2014303 citationsauthor #3
PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis
2014125 citationsauthor #17
The spectrum of latent tuberculosis: rethinking the goals of prophylaxis
201422 citationsauthor #1
PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis
2014129 citationsauthor #26
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.
2014140 citationsauthor #78
PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis
2014125 citationsauthor #16
Socioeconomic position and treatment adherence of tuberculosis in South Korea : A prospective study in 2005-2012
20130 citationsauthor #4
Impact of Diabetes and Smoking on Mortality in Tuberculosis
201390 citationsauthor #14
Tuberculosis Pulmonary Multidrug-Resistant Efficacy and Safety of Metronidazole for
20130 citationsauthor #2
Arginase Isoforms Expression of Nitric Oxide Synthase and Populations of Macrophage Subsets and Granulomas Are Delineated by Distinct Microenvironments in Tuberculous
20130 citationsauthor #8
TuberculosisMultidrug-Resistant Efficacy and Safety of Metronidazole for
20130 citationsauthor #2
Differential Virulence and Disease Progression following Mycobacterium tuberculosis Complex Infection of the Common Marmoset (Callithrix jacchus)
2013117 citationsauthor #21
Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens
2013182 citationsauthor #12
Linezolid for treatment of chronic extensively drug-resistant tuberculosis.
2012542 citationsauthor #28
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.
2012217 citationsauthor #31
Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.
2012245 citationsauthor #3
Frequency of adverse reactions to first- and second-line anti-tuberculosis chemotherapy in a Korean cohort.
201270 citationsauthor #21
Infection Dynamics and Response to Chemotherapy in a Rabbit Model of Tuberculosis using [18F]2-Fluoro-Deoxy-d-Glucose Positron Emission Tomography and Computed Tomography
2012102 citationsauthor #14
Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies.
201296 citationsauthor #2
Reagent Precoated Targets for Rapid In-Tissue Derivatization of the Anti-Tuberculosis Drug Isoniazid Followed by MALDI Imaging Mass Spectrometry
201178 citationsauthor #6
Lessons from seven decades of antituberculosis drug discovery.
201133 citationsauthor #1
NEW TACTICS AGAINST TUBERCULOSIS The pandemic is growing in many places , and strains resistant to all existing drugs are emerging . To fight back , biologists are applying a host of cutting-edge drug development strategies
20110 citationsauthor #1
Linezolid For Extensively Drug Resistant Pulmonary Tuberculosis
20115 citationsauthor #17
Spectrum of latent tuberculosis — existing tests cannot resolve the underlying phenotypes: author's reply
201012 citationsauthor #1
The chemical biology of new drugs in the development for tuberculosis.
201062 citationsauthor #1
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
20091,415 citationsauthor #1
Evaluation of the diagnostic utility of a whole blood interferon- γ assay for determining the risk of exposure to Mycobacterium tuberculosis in BCG-vaccinated individuals
20090 citationsauthor #8
Unorthodox approach to the development of a new antituberculosis therapy.
200928 citationsauthor #1
Clifton E. Barry, III: TB's strategic opponent. Interviewed by Amy Maxmen.
20090 citationsauthor #1
Cell Wall: Physical Structure and Permeability
20098 citationsauthor #2
Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital.
2008111 citationsauthor #16
Confronting the scientific obstacles to global control of tuberculosis.
2008336 citationsauthor #4
Systems biological approaches in infectious diseases
200711 citationsauthor #2
Targeting the formation of the cell wall core of M. tuberculosis.
2007106 citationsauthor #1
Comprar Systems Biological Approaches in Infectious Diseases | Boshoff, Helena I. | 9783764375669 | Springer
20070 citationsauthor #2
A low-carb diet for a high-octane pathogen
200516 citationsauthor #2
A community-based tuberculosis program in Cambodia.
200421 citationsauthor #7
Modern Drug Development
20035 citationsauthor #1
The US-Japan Cooperative Medical Science Program Tuberculosis and Leprosy Panel's 36th Annual Research Conference, New Orleans, Louisiana, USA, 15-17 July 2001. Abstracts.
20020 citationsauthor #3
Abstracts of Papers Presented at the International Symposium on Current Developments in Drug Discovery for Tuberculosis
20020 citationsauthor #1
Imagination is more important than knowledge
200137 citationsauthor #1
The development of new chemotherapeutics for multidrug-resistant tuberculosis
20000 citationsauthor #1
Tuberculosis Research at the Millennium: A report from the Fourth International Conference on the Pathogenesis of Mycobacterial Infection, Stockholm, Sweden
20000 citationsauthor #3
Isolates Vivo and In Vitro , But Is Not More Virulent Induces a More Vigorous Host Response In CDC 1551 Mycobacterium tuberculosis
19990 citationsauthor #9
Hc1-mediated effects on DNA structure
19932 citationsauthor #1
Tuberculosis
193692 citationsauthor #2

TIMELINE

1936 92 citations

1993 2 citations

1999 0 citations

2000 0 citations

2001 37 citations

2002 0 citations

2003 5 citations

2004 21 citations

2005 16 citations

2007 117 citations

2008 447 citations

2009 1,451 citations

2010 74 citations

2011 116 citations

2012 1,272 citations

2013 389 citations

2014 1,444 citations

2015 1,231 citations

2016 554 citations

2017 695 citations

2018 115 citations

2019 42 citations

2020 37 citations

2021 73 citations

2022 28 citations

2023 45 citations

2024 63 citations

2025 0 citations

COAUTHOR MAP

CONCEPT FOOTPRINT